Skip to main content

Sotorasib

Placeholder slot
 (SOH-toh-RA-sib)

This page contains brief information about sotorasib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Lumakras
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Sotorasib is approved to treat:

Sotorasib is approved under FDA’s Accelerated Approval Program. As a condition of approval, confirmatory trial(s) must show that it provides a clinical benefit in these patients.

Sotorasib is also being studied in the treatment of other types of cancer.

More About Sotorasib

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

FDA Approval of KRAS Inhibitor Sotorasib for Lung Cancer Hailed as Milestone

Targeted Cancer Therapies

Overcoming a Cancer Nemesis? KRAS Inhibitor Shows Promise in Early Trial

Clinical Trials Accepting Patients

Find Clinical Trials for Sotorasib - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: